GILEAD SCIENCES, INC. 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
GS GILEAD SCIENCES, INC. | Institutional Filer | ▼ 22.15% | $1.65B | 5 |
Current Portfolio Holdings
Showing all 5 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | RCUS | Arcus Biosciences, Inc. | Healthcare | 31.4M | $968.8M | 58.76% |
| 2 | LKFT | Lakefront Biotherapeutics N.V. | Healthcare | 16.7M | $500.2M | 30.34% |
| 3 | ASMB | Assembly Biosciences, Inc. | Healthcare | 5.0M | $136.8M | 8.30% |
| 4 | KYTX | Kyverna Therapeutics, Inc. | Healthcare | 4.1M | $36.8M | 2.23% |
| 5 | XLO | Xilio Therapeutics, Inc. | Healthcare | 650K | $6.2M | 0.38% |
Showing 1 to 5 of 5 holdings